Signaling Pathway
Idactamab (INT-001) is an IgG1-?? monoclonal antibody demonstrating significant in vivo activity against a range of hematological malignancies. This antibody serves as a precursor for the synthesis of MEDI7247, a highly potent and specific antibody-drug conjugate (ADC) that targets ASCT2 (SLC1A5), offering therapeutic potential in oncology research.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Idactamab (INT-001) is an IgG1-?? monoclonal antibody demonstrating significant in vivo activity against a range of hematological malignancies. This antibody serves as a precursor for the synthesis of MEDI7247, a highly potent and specific antibody-drug conjugate (ADC) that targets ASCT2 (SLC1A5), offering therapeutic potential in oncology research. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
